HBM Healthcare Investments AG provided earnings guidance for the first nine months ended December 31, 2021. For the period, the company expected a net profit of approximately CHF 275 million for this period (previous year net profit of CHF 644.6 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
203 CHF | -0.49% |
|
+2.32% | +11.17% |
Jul. 02 | Cartesian Therapeutics Secures $130 Million Private Placement Equity Financing | MT |
May. 28 | HBM Healthcare Flags NAV Boost from Yellow Jersey-Johnson & Johnson Deal | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.17% | 1.56B | |
+27.29% | 3.39B | |
+12.82% | 1.77B | |
-11.54% | 1.25B | |
+40.85% | 955M | |
+9.28% | 662M | |
+47.34% | 615M | |
-4.17% | 516M | |
+14.60% | 418M | |
+39.77% | 339M |
- Stock Market
- Equities
- HBMN Stock
- News HBM Healthcare Investments AG
- HBM Healthcare Investments AG Provides Earnings Guidance for the First Nine Months Ended December 31, 2021